Rapid Micro Biosystems (RPID) Other financing activities (2020 - 2026)
Rapid Micro Biosystems (RPID) reported Other financing activities of $116000.0 for Q1 2026, up 28.89% on a YoY basis from $90000.0 in Q1 2025, and down 64.74% sequentially from $329000.0 in Q4 2025.
Rapid Micro Biosystems (RPID) Other financing activities (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 7 years of Other financing activities data on file, last reported at $116000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities rose 28.89% year-over-year to $116000.0; the trailing twelve-month figure through Mar 2026 stood at $517000.0 (up 237.91% YoY), and the FY2025 full-year result was $491000.0, up 112.55% from the prior year.
- Other financing activities retreated to $116000.0 in Q1 2026, from $329000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $471000.0 in Q1 2022 to a low of -$312000.0 in Q3 2022.
- A 5-year average of $113142.9 and a median of $103000.0 in 2025 frame the typical range for Other financing activities.
- Across the five-year window, Other financing activities soared 2300.0% in 2024 and plunged 514.29% in 2025, its largest moves.
- Tracing RPID's Other financing activities over 5 years: stood at $407000.0 in 2022, then plunged by 100.49% to -$2000.0 in 2023, then soared by 3250.0% to $63000.0 in 2024, then jumped by 422.22% to $329000.0 in 2025, then sank by 64.74% to $116000.0 in 2026.
- Business Quant data shows RPID's Other financing activities at $116000.0 in Q1 2026, $329000.0 in Q4 2025, and -$261000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 116,000.00 |
| Mar 31, 2026 | 116,000.00 |
| Dec 31, 2025 | 329,000.00 |
| Dec 31, 2025 | 329,000.00 |
| Sep 30, 2025 | -261,000.00 |
| Sep 30, 2025 | -261,000.00 |
| Jun 30, 2025 | 333,000.00 |
| Jun 30, 2025 | 333,000.00 |
| Mar 31, 2025 | 90,000.00 |
| Mar 31, 2025 | 90,000.00 |
| Sep 30, 2024 | 63,000.00 |
| Sep 30, 2024 | 63,000.00 |
| Mar 31, 2024 | 168,000.00 |
| Mar 31, 2024 | 168,000.00 |
| Dec 31, 2023 | -2,000.00 |
| Dec 31, 2023 | -2,000.00 |
| Sep 30, 2023 | 58,000.00 |
| Sep 30, 2023 | 58,000.00 |
| Jun 30, 2023 | 117,000.00 |
| Jun 30, 2023 | 117,000.00 |